At a glance
- Originator Nagoya University; Nonindustrial source
- Developer Nonindustrial source
- Class Antineoplastics; Depsipeptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 30 Oct 1997 No-Development-Reported for Cancer in Japan (Unknown route)
- 26 Apr 1995 New profile